Who
Meghan Joyce V
Director
Company insider
Files Form 4 as: Director, Guardant Health; Director, Boston Beer Company; Chief Operating Officer, Oscar Health.
In numbers
- Trades disclosed
- 151
- Buys
- 0
- Sells
- 16
- Bought
- $0
- Sold
- $7.1M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 14 Mar 2019
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —4,203 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —4,203 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —4,203 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | —4,203 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | $46K1,197 at $38.42 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | $335K8,803 at $38.01 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $445K3,516 at $126.52 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,197 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —8,803 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $728K5,728 at $127.11 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $83K650 at $128.02 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $14K106 at $129.31 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —1,197 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant Healthoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —8,803 at $0.00 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | $46K1,197 at $38.42 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Code M | $335K8,803 at $38.01 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $445K3,516 at $126.52 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $728K5,728 at $127.11 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $83K650 at $128.02 | filing |
| 3 Jun 2026filed 4 Jun 2026 | GH Guardant HealthDiagnostics & Labs | SEC FORM 4 Sold | $14K106 at $129.31 | filing |
News
Guardant Health (NASDAQ:GH) Stock Purchase Reported by Rep. Jonathan L. JacksonGH · dailypolitical.com · 22 Oct 2026Guardant Health (GH) Wins a New Breast Cancer Role. Can Its Growth Justify the Price?GH · insidermonkey.com · 20 Oct 2026Guardant Health (NASDAQ:GH) Director Sells $19,242.08 in StockGH · themarketsdaily.com · 19 Oct 2026
0 headlines in the last 90 days name Meghan Joyce V; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.